ZAI LAB LTD-ADR (ZLAB) Stock Analyst Ratings
NASDAQ:ZLAB - Nasdaq - US98887Q1040 - ADR - Currency: USD
ChartMill assigns a Buy % Consensus number of 78% to ZLAB. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 38.18. This target is 13.55% above the current price.
ZLAB was analyzed by 13 analysts. The buy percentage consensus is at 78. So analysts seem to be have mildly positive about ZLAB.
In the last month the buy percentage fell by 5 points. So the trust of analysts is decreasing.
ZLAB was analyzed by 13 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-03-27 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2025-03-13 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-03-07 | ScotiaBank | Initiate | Sector Outperform |
| 2025-03-03 | B of A Securities | Downgrade | Buy -> Neutral |
| 2024-10-25 | Cantor Fitzgerald | Reiterate | Overweight |
| 2024-10-21 | JP Morgan | Maintains | Overweight -> Overweight |
| 2024-08-07 | Cantor Fitzgerald | Reiterate | Overweight |
| 2024-07-12 | JP Morgan | Maintains | Overweight -> Overweight |
| 2024-07-01 | Cantor Fitzgerald | Reiterate | Overweight |
| 2024-06-25 | Cantor Fitzgerald | Reiterate | Overweight |
| 2024-02-29 | Citigroup | Maintains | Buy -> Buy |
| 2023-12-14 | Morgan Stanley | Initiate | Overweight |
| 2023-11-30 | JP Morgan | Maintains | Overweight -> Overweight |
| 2023-10-26 | Goldman Sachs | Maintains | Buy -> Buy |
| 2023-10-26 | Citigroup | Maintains | Buy -> Buy |
| 2023-10-17 | JP Morgan | Maintains | Overweight -> Overweight |
| 2023-10-09 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2023-09-18 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2023-08-10 | Cantor Fitzgerald | Initiate | Overweight |
| 2023-06-12 | B of A Securities | Maintains | Buy |
| 2023-05-11 | Citigroup | Maintains | Buy -> Buy |
| 2023-03-16 | JP Morgan | Maintains | Overweight |
| 2022-11-18 | JP Morgan | Maintains | Overweight |
| 2022-11-11 | Citigroup | Maintains | Buy |
| 2022-08-09 | Citigroup | Maintains | Buy |
| 2022-05-12 | Citigroup | Maintains | Buy |
| 2022-05-11 | SVB Leerink | Maintains | Outperform |
| 2022-04-21 | SVB Leerink | Maintains | Outperform |
| 2022-03-02 | SVB Leerink | Maintains | Outperform |
| 2021-12-15 | JP Morgan | Maintains | Overweight |